Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
Clinical trial NCT02991859 · COMPLETED
Trial details
- NCT number
- NCT02991859
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-09
- Primary completion
- 2018-12-20
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.